Yüklüyor......
Advances in sarcoma genomics and new therapeutic targets
Increasingly, human mesenchymal malignancies are classified by the abnormalities that drive their pathogenesis. While many of these aberrations are highly prevalent within particular sarcoma subtypes, few are currently targeted therapeutically. Indeed, most subtypes of sarcoma are still treated with...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3361898/ https://ncbi.nlm.nih.gov/pubmed/21753790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc3087 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|